The FDA has rejected a rare disease therapy from Disc Medicine, an early recipient of a commissioner's voucher from the ...

Several senior officials are exiting RFK Jr.'s department amid an effort to focus on drug pricing and food issues.

After a day of oral arguments in a packed courtroom, a Boston federal judge did not rule from the bench on a lawsuit from AAP against HHS focused on vaccines.

The FDA’s surprise refusal to even review Moderna’s mRNA flu vaccine is sending a chill through biotech: Companies are openly ...

Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug ahead of an expected decision by the U.S. Food and Drug Administration in April, Reuters writes, ...

That surveillance data was the nervous system of American medicine — constantly sensing, constantly warning us what was coming. Now it’s falling silent, and the CDC isn’t even telling us why. (Some of ...

In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well ...

This week on "The Readout LOUD," everything you need to know about the FDA's controversial decision to block the review of ...

Perhaps one of the most startling realities is this: The American Academy of Pediatrics, the nation’s leading professional organization for doctors who care for kids, and the nation’s federal health ...

Kennedy Jr. has removed shots from the childhood vaccination schedule and replaced members of a key immunization advisory board. The letter sent to Moderna on Tuesday by a top FDA official, Vinay ...

Today, we’ve got a ton of updates including news about venture capital funding, telehealth policy, the government’s progress on information blocking, and research into the accuracy of Apple’s new ...

In a long-debated move, the NIH will no longer characterize basic experimental studies involving humans as clinical trials.